This grant requests funding for a Statistical Center for the Intergroup Rhabdomyosarcoma Study Group (IRSG), a pediatric cooperative clinical trials group conducting ongoing research in the treatment of pediatric rhabdomyosarcoma. The IRSG Statistical Center is comprised of the IRSG Biostatistical Center, located at the University of Nebraska Medical Center in Omaha, NE and the IRSG Data Management Center, located in Arcadia, CA. The Statistical Center is responsible for all biostatistical, data management, database management, and data quality control for the IRSG. Members of the Biostatistical Center collaborate with the IRSG Group membership on study design, on study statistical considerations, on the production of interim and final reports of Group research, and on the writing of abstracts and manuscripts for publication. Statistical Center statisticians also engage in collaborative and, where appropriate, statistician-directed research using the IRSG database. The IRSG Data Management Center (IRSG/DMC) has responsibility for patient registration, central data collection, data management and data processing, and data quality control. The IRSG/DMC also monitors significant events such as severe or unusual toxicities and assures compliance with adverse drug reaction (ADR) reporting mechanisms to facilitate patients safety monitoring by IRSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA072989-06
Application #
6489194
Study Section
Subcommittee G - Education (NCI)
Program Officer
Smith, Malcolm M
Project Start
1997-01-01
Project End
2003-02-28
Budget Start
2002-01-01
Budget End
2003-02-28
Support Year
6
Fiscal Year
2002
Total Cost
$497,333
Indirect Cost
Name
National Childhood Cancer Foundation
Department
Type
DUNS #
624124301
City
Arcadia
State
CA
Country
United States
Zip Code
91006
Wolden, Suzanne L; Lyden, Elizabeth R; Arndt, Carola A et al. (2015) Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys 93:1071-6
Raney, Beverly; Huh, Winston; Hawkins, Douglas et al. (2013) Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group. Pediatr Blood Cancer 60:371-6
Skapek, Stephen X; Anderson, James R; Hill, D Ashley et al. (2013) Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study. Pediatr Blood Cancer 60:1108-12
Gupta, Abha A; Anderson, James R; Pappo, Alberto S et al. (2012) Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer 118:1130-7
Breneman, John; Meza, Jane; Donaldson, Sarah S et al. (2012) Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study. Int J Radiat Oncol Biol Phys 83:720-6
Lin, Chi; Donaldson, Sarah S; Meza, Jane L et al. (2012) Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 82:1764-70
Raney, R Beverly; Walterhouse, David O; Meza, Jane L et al. (2011) Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft J Clin Oncol 29:1312-8
Million, Lynn; Anderson, James; Breneman, John et al. (2011) Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 80:333-8
La, Trang H; Wolden, Suzanne L; Su, Zheng et al. (2011) Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 80:206-12
La, Trang H; Wolden, Suzanne L; Rodeberg, David A et al. (2011) Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 80:1151-7

Showing the most recent 10 out of 43 publications